This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA520907; GEO: GSE126072 |
| Type | Umbrella project |
| Publications | Wei J et al., "Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.", Nature, 2019 Dec;576(7787):471-476 |
| Submission | Registration date: 4-Feb-2019
Immunology, St Jude Children's Research Hospital |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 44 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 44 |
| GEO DataSets | 6 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 173076 |
| Data volume, Processed Mbytes | 5 |
| Data volume, Supplementary Mbytes | 829 |
| Parameter | Value |
|---|
| Data volume, Gbases | 1,060 |
| Data volume, Tbytes | 0.28 |
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. encompasses the following 5 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA520908 | Mus musculus | CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq] (Immunology, St Jude Children's...) | | PRJNA564279 | Mus musculus | CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq] (Immunology, St Jude Children's...) |
|
| Transcriptome or Gene expression | 3 |
BioProject
accession | Organism | Title |
|---|
| PRJNA520909 | Mus musculus | CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq] (Immunology, St Jude Children's...) | | PRJNA564283 | Mus musculus | CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq] (Immunology, St Jude Children's...) | | PRJNA564284 | Mus musculus | CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [microarray] (Immunology, St Jude Children's...) |
|